As of January 2025, KPC Pharmaceuticals has a market cap of $1.71B. This makes KPC Pharmaceuticals the world's 5595th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.10B | -2.97% |
2023 | $2.17B | 47.73% |
2022 | $1.47B | 27.78% |
2021 | $1.15B | 27.75% |
2020 | $898.66M | -19.38% |
2019 | $1.11B | 73.62% |
2018 | $642.04M | -32.46% |
2017 | $950.60M | -32.27% |
2016 | $1.40B | -32.14% |
2015 | $2.07B | 60.44% |
2014 | $1.29B | 5.21% |
2013 | $1.23B | 21.16% |
2012 | $1.01B | - |